| CD38 molecule |

PDB rendering based on 1yh3. |
| Available structures |
| PDB |
1YH3, 1ZVM, 2EF1, 2HCT, 2I65, 2I66, 2I67, 2O3Q, 2O3R, 2O3S, 2O3T, 2O3U, 2PGJ, 2PGL, 3DZF, 3DZG, 3DZH, 3DZI, 3DZJ, 3DZK, 3F6Y, 3I9M, 3I9N |
|
| Identifiers |
| Symbols |
CD38; T10 |
| External IDs |
OMIM: 107270 MGI: 107474 HomoloGene: 1345 GeneCards: CD38 Gene |
| EC number |
3.2.2.5 |
|
|
| RNA expression pattern |
 |
| More reference expression data |
| Orthologs |
| Species |
Human |
Mouse |
|
| Entrez |
952 |
12494 |
|
| Ensembl |
ENSG00000004468 |
ENSMUSG00000029084 |
|
| UniProt |
P28907 |
Q3UCS6 |
|
| RefSeq (mRNA) |
NM_001775.2 |
NM_007646.4 |
|
| RefSeq (protein) |
NP_001766.2 |
NP_031672.2 |
|
| Location (UCSC) |
Chr 4:
15.78 – 15.85 Mb |
Chr 5:
44.26 – 44.3 Mb |
|
| PubMed search |
[1] |
[2] |
|
CD38 (cluster of differentiation 38), also known as cyclic ADP ribose hydrolase is a glycoprotein[1] found on the surface of many immune cells (white blood cells), including CD4+, CD8+, B and natural killer cells. CD38 also functions in cell adhesion, signal transduction and calcium signaling.[2]
In humans, the CD38 protein is encoded by the CD38 gene which located on chromosome 4.[3][4]
[edit] Function
CD38 is a multifunctional ectoenzyme that catalyzes the synthesis and hydrolysis of cyclic ADP-ribose (cADPR) from NAD+ to ADP-ribose. These reaction products are essential for the regulation of intracellular Ca2+.[5]
[edit] Clinical significance
The loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications.[5]
The CD38 protein is a marker of cell activation. It has been connected to HIV infection, leukemias, myelomas, solid tumors, type II diabetes mellitus and bone metabolism, as well as some genetically determined conditions.
[edit] Application
CD38 has been used as a prognostic marker in leukemia.[6] It can also be used to identify plasma cells.[7][8]
[edit] References
- ^ Orciani M, Trubiani O, Guarnieri S, Ferrero E, Di Primio R (October 2008). "CD38 is constitutively expressed in the nucleus of human hematopoietic cells". J. Cell. Biochem. 105 (3): 905–12. doi:10.1002/jcb.21887. PMID 18759251.
- ^ "Entrez Gene: CD38 CD38 molecule". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=952.
- ^ Jackson DG, Bell JI (April 1990). "Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation". J. Immunol. 144 (7): 2811–5. PMID 2319135. http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=2319135.
- ^ Nata K, Takamura T, Karasawa T, Kumagai T, Hashioka W, Tohgo A, Yonekura H, Takasawa S, Nakamura S, Okamoto H (February 1997). "Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing". Gene 186 (2): 285–92. doi:10.1016/S0378-1119(96)00723-8. PMID 9074508. http://linkinghub.elsevier.com/retrieve/pii/S0378-1119(96)00723-8.
- ^ a b Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S (July 2008). "Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology". Physiol. Rev. 88 (3): 841–86. doi:10.1152/physrev.00035.2007. PMID 18626062.
- ^ Deaglio S, Mehta K, Malavasi F (2001). "Human CD38: a (r)evolutionary story of enzymes and receptors". Leuk. Res. 25 (1): 1–12. doi:10.1016/S0145-2126(00)00093-X. PMID 11137554.
- ^ Hasmoni MH, Wahid FA, Keng CS (January 2009). "Primary plasma cell leukemia presented as progressive paraplegia: a case report". South. Med. J. 102 (1): 101–3. doi:10.1097/SMJ.0b013e31818018c1. PMID 19077786. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/SMJ.0b013e31818018c1.
- ^ Rawstron AC (May 2006). "Immunophenotyping of plasma cells". Curr Protoc Cytom Chapter 6: Unit6.23. doi:10.1002/0471142956.cy0623s36. ISBN 0471142956. PMID 18770841.
[edit] Further reading
- States DJ, Walseth TF, Lee HC (1993). "Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38". Trends Biochem. Sci. 17 (12): 495. doi:10.1016/0968-0004(92)90337-9. PMID 1471258.
- Malavasi F, Funaro A, Roggero S, et al. (1994). "Human CD38: a glycoprotein in search of a function". Immunol. Today 15 (3): 95–7. doi:10.1016/0167-5699(94)90148-1. PMID 8172650.
- Guse AH (1999). "Cyclic ADP-ribose: a novel Ca2+-mobilising second messenger". Cell. Signal. 11 (5): 309–16. doi:10.1016/S0898-6568(99)00004-2. PMID 10376802.
- Funaro A, Malavasi F (1999). "Human CD38, a surface receptor, an enzyme, an adhesion molecule and not a simple marker". J. Biol. Regul. Homeost. Agents 13 (1): 54–61. PMID 10432444.
- Mallone R, Perin PC (2006). "Anti-CD38 autoantibodies in type? diabetes". Diabetes Metab. Res. Rev. 22 (4): 284–94. doi:10.1002/dmrr.626. PMC 2763400. PMID 16544364. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2763400.
- Partidá-Sánchez S, Rivero-Nava L, Shi G, Lund FE (2007). "CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses". Adv. Exp. Med. Biol.. Advances in Experimental Medicine and Biology 590: 171–83. doi:10.1007/978-0-387-34814-8_12. ISBN 978-0-387-34813-1. PMID 17191385.
- Jackson DG, Bell JI (1990). "Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation". J. Immunol. 144 (7): 2811–5. PMID 2319135.
- Dianzani U, Bragardo M, Buonfiglio D, et al. (1995). "Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120". Eur. J. Immunol. 25 (5): 1306–11. doi:10.1002/eji.1830250526. PMID 7539755.
- Nakagawara K, Mori M, Takasawa S, et al. (1995). "Assignment of CD38, the gene encoding human leukocyte antigen CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase), to chromosome 4p15". Cytogenet. Cell Genet. 69 (1–2): 38–9. doi:10.1159/000133933. PMID 7835083.
- Tohgo A, Takasawa S, Noguchi N, et al. (1994). "Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38". J. Biol. Chem. 269 (46): 28555–7. PMID 7961800.
- Takasawa S, Tohgo A, Noguchi N, et al. (1994). "Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP". J. Biol. Chem. 268 (35): 26052–4. PMID 8253715.
- Nata K, Takamura T, Karasawa T, et al. (1997). "Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing". Gene 186 (2): 285–92. doi:10.1016/S0378-1119(96)00723-8. PMID 9074508.
- Feito MJ, Bragardo M, Buonfiglio D, et al. (1997). "gp 120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules". Int. Immunol. 9 (8): 1141–7. doi:10.1093/intimm/9.8.1141. PMID 9263011.
- Ferrero E, Malavasi F (1997). "Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase". J. Immunol. 159 (8): 3858–65. PMID 9378973.
- Deaglio S, Morra M, Mallone R, et al. (1998). "Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member". J. Immunol. 160 (1): 395–402. PMID 9551996.
- Yagui K, Shimada F, Mimura M, et al. (1998). "A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro". Diabetologia 41 (9): 1024–8. doi:10.1007/s001250051026. PMID 9754820.
|
PDB gallery
|
|
|
|
|
1yh3: Crystal structure of human CD38 extracellular domain
|
|
|
|
1zvm: Crystal structure of human CD38: cyclic-ADP-ribosyl synthetase/NAD+ glycohydrolase
|
|
|
|
2ef1: Crystal structure of the extracellular domain of human CD38
|
|
|
|
2hct: Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine NAAPD synthesis and hydrolysis activities
|
|
|
|
2i65: Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis
|
|
|
|
2i66: Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis
|
|
|
|
2i67: Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis
|
|
|
|
2o3q: Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38
|
|
|
|
2o3r: Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38
|
|
|
|
2o3s: Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38
|
|
|
|
2o3t: Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38
|
|
|
|
2o3u: Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38
|
|
|
|
2pgj: Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzable substrate analog
|
|
|
|
2pgl: Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog
|
|
|
|
[edit] External links
|
|
|
| 1-50 |
CD1 ( a-c, 1A, 1D, 1E) · CD2 · CD3 ( γ, δ, ε) · CD4 · CD5 · CD6 · CD7 · CD8 ( a) · CD9 · CD10 · CD11 ( a, b, c) · CD13 · CD14 · CD15 · CD16 ( A, B) · CD18 · CD19 · CD20 · CD21 · CD22 · CD23 · CD24 · CD25 · CD26 · CD27 · CD28 · CD29 · CD30 · CD31 · CD32 ( A, B) · CD33 · CD34 · CD35 · CD36 · CD37 · CD38 · CD39 · CD40 · CD41 · CD42 ( a, b, c, d) · CD43 · CD44 · CD45 · CD46 · CD47 · CD48 · CD49 ( a, b, c, d, e, f) · CD50
|
|
| 51-100 |
CD51 · CD52 · CD53 · CD54 · CD55 · CD56 · CD57 · CD58 · CD59 · CD61 · CD62 ( E, L, P) · CD63 · CD64 ( A, B, C) · CD66 ( a, b, c, d, e, f) · CD68 · CD69 · CD70 · CD71 · CD72 · CD73 · CD74 · CD78 · CD79 ( a, b) · CD80 · CD81 · CD82 · CD83 · CD84 · CD85 ( a, d, e, h, j, k) · CD86 · CD87 · CD88 · CD89 · CD90 · CD91- CD92 · CD93 · CD94 · CD95 · CD96 · CD97 · CD98 · CD99 · CD100
|
|
| 101-150 |
|
|
| 151-200 |
CD151 · CD152 · CD153 · CD154 · CD155 · CD156 ( a, b, c) · CD157 · CD158 ( a, d, e, i, k) · CD159 ( a, c) · CD160 · CD161 · CD162 · CD163 · CD164 · CD166 · CD167 ( a, b) · CD168 · CD169 · CD170 · CD171 · CD172 ( a, b, g) · CD174 · CD177 · CD178 · CD179 ( a, b) · CD181 · CD182 · CD183 · CD184 · CD185 · CD186 · CD191 · CD192 · CD193 · CD194 · CD195 · CD196 · CD197 · CDw198 · CDw199 · CD200
|
|
| 201-250 |
|
|
| 251-300 |
|
|
| 301-350 |
|
|